Van der Veen F, Mugala-Mukungu F, Kangudi M, Feris A, Katjitae I, Colebunders R
Department Epidemiology and Social Medicine, University of Antwerpen, Belgium.
Int J STD AIDS. 2011 Oct;22(10):577-80. doi: 10.1258/ijsa.2011.010452.
Antiretroviral treatment (ART) has been available in the private sector in Namibia since 1998. National guidelines were developed by the Ministry of Health and clinicians of the public and private sector in 2003 and launched at the start of the public sector ART programme by the Ministry of Health. The Namibian HIV Clinicians Society was established around this period to promote adherence to the national guidelines and to provide comprehensive training for health professionals. To monitor adherence to national ART guidelines, in 2003, the Society requested access to anonymized data on ART dispensing from the medical insurance industry. Dispensing data from all Namibian medical insurance companies were obtained. ART regimens were categorized as recommended (non-nucleoside reverse transcriptase inhibitor-based and boosted protease inhibitor [PI]-based), not recommended (non-boosted PI-based or stavudine/didanosine-containing regimens), ineffective (dual therapy) and second line or salvage regimens. This analysis was repeated in 2004, 2005 and 2008. In 2003, only 2306 adult private patients received ART, of which only 1527 (66%) were recommended regimens. In 2008, 7010 private patients received ART, of which 6372 (91%) were recommended regimens. The private sector covered about 15% of the total number of 46,732 reported ART patients reported in the year 2008. Many of these private patients might not have accessed ART in the public sector.
自1998年起,纳米比亚的私营部门就已提供抗逆转录病毒治疗(ART)。2003年,纳米比亚卫生部以及公共和私营部门的临床医生制定了国家指南,并由卫生部在公共部门抗逆转录病毒治疗计划启动时予以发布。纳米比亚艾滋病毒临床医生协会大约在这一时期成立,旨在促进对国家指南的遵守,并为卫生专业人员提供全面培训。为监测对国家抗逆转录病毒治疗指南的遵守情况,该协会于2003年请求从医疗保险行业获取抗逆转录病毒治疗配药的匿名数据。获取了纳米比亚所有保险公司的配药数据。抗逆转录病毒治疗方案被分类为推荐方案(基于非核苷类逆转录酶抑制剂和增强型蛋白酶抑制剂[PI])、非推荐方案(基于非增强型PI或含司他夫定/去羟肌苷的方案)、无效方案(二线治疗)以及二线或挽救方案。2004年、2005年和2008年重复了这一分析。2003年,仅有2306名成年私营患者接受了抗逆转录病毒治疗,其中只有1527名(66%)采用的是推荐方案。2008年,7010名私营患者接受了抗逆转录病毒治疗,其中6372名(91%)采用的是推荐方案。2008年报告的46732名接受抗逆转录病毒治疗患者中,私营部门覆盖了约15%。这些私营患者中的许多人可能无法在公共部门获得抗逆转录病毒治疗。